Tivity Health EPS beats by $0.06, revenue in-line

Tivity Health (NASDAQ:TVTY): Q1 Non-GAAP EPS of -$0.12 beats by $0.06; GAAP EPS of -$4.08 misses by $3.79.

Revenue of $337.66M (+57.7% Y/Y) in-line.

Shares +9.88%.

Press Release

https://seekingalpha.com/news/3570509-tivity-health-eps-beats-0_06-revenue-in-line

Amedisys EPS beats by $0.08, misses on revenue

Amedisys  (NASDAQ:AMED): Q1 Non-GAAP EPS of $1.05 beats by $0.08; GAAP EPS of $0.96 misses by $0.01.

Revenue of $491.69M (+5.2% Y/Y) misses by $15.76M.

Press Release

https://seekingalpha.com/news/3570474-amedisys-and-nbsp-eps-beats-0_08-misses-on-revenue

Nu Skin EPS beats by $0.12, beats on revenue

Nu Skin (NYSE:NUS): Q1 GAAP EPS of $0.36 beats by $0.12.

Revenue of $518.03M (-16.9% Y/Y) beats by $41.02M.

Shares +8.86%.

Press Release

https://seekingalpha.com/news/3570493-nu-skin-eps-beats-0_12-beats-on-revenue

Lannett EPS misses by $0.01, beats on revenue

Lannett (NYSE:LCI): Q3 Non-GAAP EPS of $0.27 misses by $0.01; GAAP EPS of -$0.43 misses by $0.57.

Revenue of $144.4M (-16.4% Y/Y) beats by $9.85M.

Shares -5%.

Press Release

https://seekingalpha.com/news/3570528-lannett-eps-misses-0_01-beats-on-revenue

Veracyte EPS misses by $0.04, beats on revenue

Veracyte (NASDAQ:VCYT): Q1 GAAP EPS of -$0.24 misses by $0.04.

Revenue of $31.12M (+5.4% Y/Y) beats by $0.06M.

Press Release

https://seekingalpha.com/news/3570531-veracyte-eps-misses-0_04-beats-on-revenue

Quidel beats on revenue

Quidel (OTC:QDEL): Q1 Non-GAAP EPS of $1.22; GAAP EPS of $0.93.

Revenue of $174.65M (+18.0% Y/Y) beats by $14.04M.

Shares +2.33%.

Press Release

https://seekingalpha.com/news/3570541-quidel-beats-on-revenue

Opko Health Q1 revenues down 5% due to COVID-19 headwinds

OPKO Health (NASDAQ:OPK) Q1 results:

Total revenue: $211.5M (-4.9%); lab services: $170.8M (-4.5%); product sales: $31.1M (+22.9%). Decline in lab services due to COVID-19 disruptions (outweighed the increase from pandemic-related testing).

Net loss: ($59.1M); loss/share: ($0.09).

BioReference Laboratories unit has run 700K COVID-19 tests to date and can handle 35K per day. Capacity will expand to 400K/day within the next two weeks.

Rayaldee prescriptions up 78% from a year ago to ~18,327.

16K 4Kscore tests performed.

Shares down 2% after hours.

OPKO Health EPS in-line, misses on revenue

https://seekingalpha.com/news/3570536-opko-health-q1-revenues-down-5-due-to-covidminus-19-headwinds